Maternal exposure to perfluorinated chemicals and reduced fecundity: The MIREC study

Human Reproduction

Volumn 30, Issue 3, 2015, Pages 701-709

  Velez M P ^a   Arbuckle, T E ^b   Fraser, W D ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Environmental Health Center   (Canada)

Author keywords

Fecundity; Perfluorohexane sulfonate; Perfluorooctane sulfonate; Perflurooctanoic acid; Time to pregnancy

Indexed keywords

PERFLUORO COMPOUND; PERFLUOROHEXANE SULFONATE; PERFLUOROOCTANESULFONIC ACID; PERFLUROOCTANOIC ACID; UNCLASSIFIED DRUG; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; PERFLUOROHEXANESULFONIC ACID; PERFLUOROOCTANOIC ACID; SULFONIC ACID DERIVATIVE;

ARTICLE; BIRTH CONTROL; BLOOD LEVEL; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; MATERNAL AGE; MATERNAL PLASMA; OBESITY; PATERNAL AGE; PREGNANCY; QUESTIONNAIRE; RETROSPECTIVE STUDY; SPERM DONOR; TIME TO PREGNANCY; ADULT; CANADA; COHORT ANALYSIS; DRUG EFFECTS; MATERNAL EXPOSURE;

ADULT; ALKANESULFONIC ACIDS; CANADA; CAPRYLATES; COHORT STUDIES; FEMALE; FLUOROCARBONS; HUMANS; MATERNAL EXPOSURE; SULFONIC ACIDS; TIME-TO-PREGNANCY;

EID: 84935085767     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu350     Document Type: Article

References (50)

1. 3M. 3M's Phase Out and New Technologies. http://solutions.3m.com/wps/portal/3M/en-US/PFOS/PFOA/Information/phase-out-technologies/(16 June 2014, date last accessed), 2014.
2. Allison PD. Survival Analysis Using SAS: A Practical Guide, 2nd edn. Cary, NC: SAS Institute Inc., 2010.
3. Arbuckle TE, Fraser WD, Fisher M, Davis K, Liang CL, Lupien N, Bastien S, Velez MP, von Dadelszen P, Hemmings DG et al. Cohort profile: the maternal-infant research on environmental chemicals research platform. Paediatr Perinat Epidemiol 2013a;27:415-425.
4. Arbuckle TE, Kubwabo C, Walker M, Davis K, Lalonde K, Kosarac I, Wen SW, Arnold DL. Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants. Int J Hyg Environ Health 2013b; 216:184-194.
5. ATSDR. Draft Toxicological Profile for Perfluoroalkyls. Agency for Toxic Substances and Disease Registry, 2009. http://www.atsdr.cdc.gov/toxfaqs/tf.asp?id=1116&tid=237 (date last accessed, 16 June 2014).
6. Austin ME, Kasturi BS, Barber M, Kannan K, Mohan Kumar PS, Mohan Kumar SM. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ Health Perspect 2003;111:1485-1489.
7. Bjorklund JA, Thuresson K, De Wit CA. Perfluoroalkyl compounds (PFCs) in indoor dust: concentrations, human exposure estimates, and sources. Environ Sci Technol 2009;43:2276-2281.
8. Buck Louis GM, Peterson CM, Chen Z, Hediger ML, Croughan MS, Sundaram R, Stanford JB, Fujimoto VY, Varner MW, Giudice LC et al. Perfluorochemicals and endometriosis: the ENDO study. Epidemiology 2012;23:799-805.
9. Buck Louis GM, Sundaram R, Schisterman EF, Sweeney AM, Lynch CD, Gore-Langton RE, Maisog J, Kim S, Chen Z, Barr DB. Persistent environmental pollutants and couple fecundity: the LIFE study. Environ Health Perspect 2013;121:231-236.
10. Buck Louis GM, Sundaram R, Sweeney AM, Schisterman EF, Maisog J, Kannan K. Urinary bisphenol A, phthalates, and couple fecundity: the Longitudinal Investigation of Fertility and the Environment (LIFE) Study. Fertil Steril 2014;101:1359-1366.
11. Centers for Disease Control and Prevention. Fourth National Report on Human Exposure to Environmental Chemicals, 2009.
12. Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, Lau C, Singh RJ, Wallace KB, Butenhoff JL. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 2008;243:330-339.
13. Cooney MA, Buck Louis GM, Sundaram R, McGuiness BM, Lynch CD. Validity of self-reported time to pregnancy. Epidemiology 2009;20: 56-59.
14. Dallaire R, Dewailly E, Pereg D, Dery S, Ayotte P. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ Health Perspect 2009;117:1380-1386.
15. Ding J, Zhou H, Liu Y, Cai J, Longnecker MP. Estimating effect ofenvironmental contaminants on women's subfecundity for the Mo Ba study data with an outcome-dependent sampling scheme. Biostatistics 2014;15:636-650.
16. Du Pont. About PFOA. http://www2.dupont.com/PFOA2/en-US/index.html (8 December 2014, date last accessed), 2013.
17. Environment Canada. Perfluorooctane Sulfonate and its Salts and Certain Other Compounds Regulations (PFOS Regulations). 2012; http://www.ec.gc.ca/toxiques-toxics/4284EC2C-8BA0-4049-AF03-994FD409D523/907-PFOS%20factsheet-04-e.pdf (date last accessed, 16 June 2014).
18. Fei C, McLaughlin JK, Lipworth L, Olsen J. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 2009;24:1200-1205.
19. Fei C, Weinberg CR, Olsen J. Commentary: perfluorinated chemicals and time to pregnancy: a link based on reverse causation? Epidemiology 2012; 23:264-266.
20. Fromme H, Tittlemier SA, Volkel W, Wilhelm M, Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int J Hyg Environ Health 2009;212:239-270.
21. Fromme H, Mosch C, Morovitz M, Alba-Alejandre I, Boehmer S, Kiranoglu M, Faber F, Hannibal I, Genzel-Boroviczeny O, Koletzko B et al. Pre-and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol 2010;44:7123-7129.
22. Greenland S. Quantifying biases in causal models: classical confounding 1 collider-stratification bias. Epidemiology 2003;14:300-306.
23. Han X, Snow TA, Kemper RA, Jepson GW. Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol 2003; 16:775-781.
24. Health Canada. Perfluorooctane Sulfonate (PFOS) and Health. http://www.hc-sc.gc.ca/ewh-semt/pubs/contaminants/perflurooctane-sulfonate-eng.php (16 June 2014, date last accessed), 2008.
25. Health Canada. Report on Human Biomonitoring of Environmental Chemicals in Canada. Results of the Canadian Health Measures Survey Cycle 1 (2007-2009). 2010; http://www.hc-sc.gc.ca/ewh-semt/alt-formats/hecs-sesc/pdf/pubs/contaminants/chms-ecms/report-rapport-eng.pdf (date last accessed, 16 June 2014).
26. Health Canada. Second Report on Human Biomonitoring of Environmental Chemicals in Canada. Results of the Canadian Health Measures Survey Cycle 2 (2009-2011). 2013; http://www.hc-sc.gc.ca/ewh-semt/pubs/contaminants/chms-ecms-cycle2/index-eng php, (date last accessed, 16 June 2014).
27. Hoffman K, Webster TF, Bartell SM, Weisskopf MG, Fletcher T, Vieira VM. Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility. Environ Health Perspect 2011;119:92-97.
28. Howards PP, Schisterman EF, Poole C, Kaufman JS, Weinberg CR. 'Toward a clearerdefinition ofconfounding' revisited with directed acyclicgraphs. Am J Epidemiol 2012;176:506-511.
29. Joffe M, Key J, Best N, Keiding N, Scheike T, Jensen TK. Studying time to pregnancy by use of a retrospective design. Am J Epidemiol 2005; 162:115-124.
30. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. Trends in exposure to polyfluoroalkyl chemicals in the U. S. Population: 1999-2008. Environ Sci Technol 2011;45:8037-8045.
31. Kjeldsen LS, Bonefeld-Jorgensen EC. Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int 2013; 20:8031-8044.
32. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 2003;74:382-392.
33. Lim TC, Wang B, Huang J, Deng S, Yu G. Emission inventory for PFOSin China: review of past methodologies and suggestions. Scientific World Journal 2011; 11:1963-1980.
34. Loccisano AE, Longnecker MP, Campbell JL Jr, Andersen ME, Clewell HJ III. Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages. J Toxicol Environ Health A 2013;76:25-57.
35. Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL. Neonatal mortality from in uteroexposureto perfluorooctanesulfonate(PFOS)inSprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 2005;215:149-169.
36. Nohr EA, Frydenberg M, Henriksen TB, Olsen J. Does low participation in cohort studies induce bias? Epidemiology 2006;17:413-418.
37. Nost TH, Vestergren R, Berg V, Nieboer E, Odland JO, Sandanger TM. Repeated measurements of per-and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort. Environ Int 2014;67:43-53.
38. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, Zobel LR. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007;115:1298-1305.
39. Olsen GW, Butenhoff JL, Zobel LR. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol 2009;27:212-230.
40. Sallmen M, Bonde JP, Lindbohm ML, Kristensen P. Selection bias due to parity-conditioning in studies of time trends in fertility. Epidemiology 2015;26:85-90.
41. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 2009;20:488-495.
42. Shoeib M, Harner T, Ikonomou M, Kannan K. Indoor and outdoor air concentrations and phase partitioning of perfluoroalkyl sulfonamides and polybrominated diphenyl ethers. Environ Sci Technol 2004;38:1313-1320.
43. Shoeib M, Harner T, MWebster G, Lee SC. Indoor sources of poly-and perfluorinated compounds (PFCS) in Vancouver, Canada: implications for human exposure. Environ Sci Technol 2011;45:7999-8005.
44. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 2003;74:369-381.
45. Tittlemier SA, Pepper K, Seymour C, Moisey J, Bronson R, Cao XL, Dabeka RW. Dietary exposure of Canadians to perfluorinated carboxylates and perfluorooctane sulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. J Agric Food Chem 2007;55:3203-3210.
46. Vestergaard S, Nielsen F, Andersson AM, Hjollund NH, Grandjean P, Andersen HR, Jensen TK. Association between perfluorinated compounds and time to pregnancy in a prospective cohort of Danish couples attempting to conceive. Hum Reprod 2012;27:873-880.
47. Wang Y, Rogan WJ, Chen PC, Lien GW, Chen HY, Tseng YC, Longnecker MP, Wang SL. Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohortstudy. Environ Health Perspect 2014;122:529-534.
48. Weinberg CR, Wilcox AJ. Methodological issues in reproductive epidemiology. In: Rothman KJ, Greenland S, Lash TL (eds). Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins, 2008, 620-640.
49. Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, Thomsen C, Eggesbo M, Travlos G, Wilson R et al. Perfluorinated compounds and subfecundity in pregnant women. Epidemiology 2012; 23:257-263.
50. Zielhuis GA, Hulscher ME, Florack EI. Validity and reliabilityofaquestionnaire on fecundability. Int J Epidemiol 1992;21:1151-1156.